Opus Point Partners Management, LLC - Q1 2015 holdings

$119 Million is the total value of Opus Point Partners Management, LLC's 65 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 100.0% .

 Value Shares↓ Weighting
EXAS ExitPUT/EXAS @ 21 EXP 04/17/2015put$0-50
-100.0%
-0.01%
ExitCALL/PCYC @ 130 EXP 01/17/2015call$0-150
-100.0%
-0.04%
ExitCALL/BIIB @ 355 EXP 01/17/2015call$0-120
-100.0%
-0.27%
XOMA ExitXOMA CORP DEL CMN$0-80,000
-100.0%
-0.28%
ExitCALL/ALXN @ 150 EXP 01/17/2015call$0-100
-100.0%
-0.35%
ExitCALL/INCY @ 70 EXP 01/17/2015call$0-886
-100.0%
-0.48%
ExitCALL/ILMN @ 180 EXP 01/17/2015call$0-250
-100.0%
-0.54%
P103PS ExitNPS PHARMACEUTICALS INC CMN$0-15,471
-100.0%
-0.55%
CBST ExitCUBIST PHARMACEUTICALS, INC. CMN$0-6,502
-100.0%
-0.65%
XBI ExitSPDR S&P BIOTECH ETF ETFs&p biotech$0-20,800
-100.0%
-3.84%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-05-18
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
METTLER-TOLEDO INTL CMN20Q3 20194.7%
ALNYLAM PHARMACEUTICALS, INC. CMN20Q3 20195.0%
VERTEX PHARMACEUTICALS INC CMN20Q3 20194.0%
ILLUMINA, INC. CMN20Q3 20194.4%
SEATTLE GENETICS, INC. CMN20Q3 20194.0%
ALEXION PHARMACEUTICALS INC CMN20Q3 20194.3%
INCYTE CORPORATION CMN20Q3 20194.4%
NEKTAR THERAPEUTICS CMN20Q3 20194.9%
REGENERON PHARMACEUTICALS20Q3 20193.8%
CELGENE CORPORATION CMN20Q3 20193.8%

View Opus Point Partners Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
13F-HR2018-11-14
13F-HR2018-08-14
13F-HR2018-05-15
13F-HR2018-02-14
13F-HR/A2017-11-17
13F-HR2017-11-14

View Opus Point Partners Management, LLC's complete filings history.

Compare quarters

Export Opus Point Partners Management, LLC's holdings